Text
Biologic Therapy For Psoriasis Patients Terapi Biologik pada Pasien Psoriasis
Treatment limitations of current immunosuppressive therapies, and growing understanding of psoriasis pathogenesis on a molecular level have stimulated much interest in the field of immunomodulatory therapy for management of psoriasis. Genetic engineering has allowed the development of proteins that are targeted to specific cell surface receptors. A well over 40 tergeted biologic agents are in preclinical and clinical testing for T-cell mediated inflammatory diseases, including psoriasis/ It is important that, as a doctor become well educated in biologies,since several of these agents are available for the management of psoriasis
No other version available